The activation of PI3K/Akt signaling has been demonstrated to stimulate Slug expression via GSK-3β/β-catenin signaling and to subsequently down-regulate E-cadherin in uterine carcinosarcomas and normal hepatocytes [43], [58]. The gene discussed is SNAI2; the disease is uterine carcinosarcoma.